一种具有成本效益的治疗方法,使用罗斯瓦斯塔丁+克洛皮多格雷尔固定剂量组合 (FDC) 来增强坚持:一个回顾性,非比较性,现实世界的印度研究
Kishor Pargaonkar1, Sanjeev Chaudhary2, Arijit Roy Choudhury3
1Cardiology, Pargaonkar Hospital, Aurangabad, IND.
Cureus
|September 8, 2025
概括
罗斯瓦斯塔丁和克洛皮多格勒的固定剂量组合在心血管疾病管理中显示出高坚持性和耐受性. 成本效益和简化剂量是推动患者遵守的关键因素.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 药物坚持显著影响心血管疾病 (CVD) 管理.
- 具有成本效益的治疗策略对于长期控制疾病至关重要.
- 固定剂量组合 (FDC) 在简化治疗方案方面提供了潜在的好处.
研究的目的:
- 为了评估药物对罗苏瓦斯塔丁和克洛皮多格雷尔具有成本效益的固定剂量组合 (FDC) 的坚持.
- 评估这种FDC在患有动脉样硬化心血管疾病 (ASCVD),后急性冠状动脉综合征 (ACS) 或高心血管风险的患者的疗效和耐受性.
- 为了确定影响这种组合疗法的坚持因素.
主要方法:
- 在100个印度医疗保健中心进行了回顾性,非随机的,非比较的多中心研究.
- 包括年龄≥18岁的患者,因为ASCVD,后ACS或高心血管风险而处方罗苏瓦斯塔丁和克洛皮多格勒.
- 收集关于患者人口统计,并发症,处方剂量,坚持率,坚持原因和医生总体评估的数据.
主要成果:
- 95.49% (931/975名患者) 的高坚持率对罗斯瓦斯塔丁-克洛皮多格雷尔FDC.
- 坚持的主要驱动因素是降低成本 (68.92%) 和简化剂量 (60.41%).
- 医生在超过56%的病例中将这种组合的疗效和耐受性评为优异. 较高的罗斯瓦斯塔丁剂量 (20mg) 显示了显著更好的医生评级.
结论:
- 罗斯瓦斯塔丁-克洛皮多格勒FDC耐受性良好,并且在治疗ASCVD,后ACS和高心血管风险患者方面表现出很高的坚持.
- 成本效益和简化剂量是促进对这种心血管药物的坚持的关键因素.
- FDC代表了长期心血管疾病管理的有价值和有效的治疗选择.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
Coronary Artery Disease IV: Preventive Measures
591
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591

